Veracyte | VCYT - Umsatzkosten

Aktienkurs
31.09
Täglich Wechseln
-0.26 -0.83%
Monatlich
-4.22%
Jährlich
-2.23%
Q2 Prognose
30.24




Umsatzkosten Veränderung Datum
Agenus USD 642K 399K 2025-09
Agilent USD 852M 19M 2025-12
Anika Therapeutics USD 11.44M 797K 2025-12
Bruker USD 528M 46.9M 2025-12
Heron Therapeutics USD 11.12M 795K 2025-12
Illumina USD 400M 49M 2025-12
Intrexon USD 1.01M 344K 2024-06
Karyopharm Therapeutics USD 1.48M 35.95M 2025-12
Laboratory Of America USD 2.6B 56.8M 2025-12
Ligand Pharmaceuticals USD 11.9M 733K 2025-09
Myriad Genetics USD 63M 1.1M 2025-12
Rigel Pharmaceuticals USD 8.03M 5.22M 2024-09
Roche Holding CHF 8.48B 4.61B 2025-12
Sangamo BioSciences 2.42M 1.11M 2024-06
Siemens EUR 11.51B 1.82B 2025-12
Sonic Healthcare AUD 751.66M 801.13M 2024-12
Thermo Fisher Scientific USD 7.58B 674M 2025-12
Veracyte USD 39.28M 1.93M 2025-12
Waters USD 374.94M 47.13M 2025-12